NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $400,000 | -41.2% | 20,000 | -50.0% | 0.01% | -43.8% |
| Q4 2020 | $680,000 | -18.1% | 40,000 | -20.0% | 0.02% | -50.0% |
| Q3 2020 | $830,000 | -71.3% | 50,000 | -60.0% | 0.03% | -70.9% |
| Q2 2020 | $2,895,000 | +8.1% | 125,000 | -16.7% | 0.11% | -11.3% |
| Q1 2020 | $2,678,000 | -38.0% | 150,000 | -25.0% | 0.12% | -27.9% |
| Q4 2019 | $4,317,000 | -70.0% | 200,000 | -74.6% | 0.17% | -80.3% |
| Q3 2019 | $14,368,000 | +1.0% | 788,800 | +97.2% | 0.88% | +7.1% |
| Q2 2019 | $14,232,000 | -15.3% | 400,000 | -20.0% | 0.82% | -28.0% |
| Q1 2019 | $16,800,000 | -35.9% | 500,000 | -37.3% | 1.14% | -46.6% |
| Q4 2018 | $26,198,000 | -84.1% | 797,000 | -70.5% | 2.13% | -80.1% |
| Q3 2018 | $164,494,000 | +1.2% | 2,698,400 | -18.9% | 10.69% | -11.1% |
| Q2 2018 | $162,526,000 | -62.6% | 3,328,400 | -18.7% | 12.03% | -62.9% |
| Q1 2018 | $435,039,000 | +165.1% | 4,094,100 | +49.0% | 32.43% | +88.8% |
| Q4 2017 | $164,093,000 | +470.0% | 2,747,700 | +35.8% | 17.18% | +320.8% |
| Q2 2016 | $28,786,000 | +4.7% | 2,022,879 | +1.1% | 4.08% | -1.5% |
| Q1 2016 | $27,500,000 | +113.3% | 2,000,000 | +161.4% | 4.14% | +168.7% |
| Q4 2015 | $12,893,000 | +195.9% | 765,156 | +92.5% | 1.54% | +121.6% |
| Q3 2015 | $4,357,000 | -12.4% | 397,500 | 0.0% | 0.70% | +5.3% |
| Q2 2015 | $4,973,000 | +13.7% | 397,500 | 0.0% | 0.66% | -2.2% |
| Q1 2015 | $4,373,000 | -37.3% | 397,500 | -11.7% | 0.68% | -37.2% |
| Q4 2014 | $6,975,000 | +28.4% | 450,000 | 0.0% | 1.08% | -3.7% |
| Q3 2014 | $5,432,000 | – | 450,000 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |